Featured,Shroom News Miami Based Emotional Intelligence Ventures Raises $20 Million for Mental Wellness By Dennis Mutua October 22, 2021 Miami based company empowering mental wellness through psychoactive compounds and technology, Emotional Intelligence Ventures announced having raised $20 million in a Regulation A offering which it will be using to advance mental ...
Psychedelic Stocks,Shroom News Numinus Progresses Phase 1 Clinical Trial on Proprietary Psilocybin Product By Dennis Mutua October 21, 2021 Health care company focused on merging latest psychedelics medicine with best evidenced-based care and a holistic integrated approach to treating mental conditions Numinus Wellness Inc. (CVE: NUMI) announced having finished the st...
Featured,Shroom News COMPASS Pathways Secures UPTSO Patent for Crystalline Psilocybin By Dennis Mutua October 20, 2021 Mental healthcare company focusing on speeding patient access to evidence-based innovation in mental health COMPASS Pathways Plc. (NASDAQ: CMPS) announced having secured patent approval from United States Patent and Trademark Offi...
Psychedelic Stocks,Shroom News Russell Peters to Have His First Psychedelic Experience With Red Light Holland By Dennis Mutua October 19, 2021 Psychedelic focused company specializing on production and sale of medical grade truffles Red Light Holland (CSE: TRIP) (OTC PINK: TRUFF) announced that its chief creative officer, Russell Peters, will be taking part in his first ...
Psychedelic Stocks,Shroom News MindMed Joins Clinical Trials Transformation Initiative By Dennis Mutua October 15, 2021 Psychedelic medicine biotech company developing psychedelic-inspired medicine and therapies to treat addiction and mental conditions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced having joined Clinical Trials Transformation In...
Psychedelic Stocks,Shroom News Atai Life Sciences Launches PsyProtix to Develop Psychiatric Therapy for TRD By Dennis Mutua October 13, 2021 Clinical stage biopharmaceutical company seeking to transform the treatment of mental health disorders Atai Life Sciences NV (NASDAQ: ATAI) announced having launched PsyProtix a precision unit specializing on developing therapeuti...
Psychedelic Stocks,Shroom News Psyched Wellness Commences Pre-Clinical Trial Study of Amanita Muscaria (AME-1) By Dennis Mutua October 11, 2021 Health supplement company focusing on protecting, restoring and regaining a healthier body and mind through production and distribution of medical mushrooms Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYFC) announced having commenc...
Psychedelic Stocks,Shroom News Tryp Therapeutics Enters Into a Partnership With Researchers From University of Wisconsin-Madison By Dennis Mutua October 08, 2021 Pharmaceutical company focusing on identifying and developing psychedelic drugs beyond mental health Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) announced having entered into a partnership with researchers from University of...
